Results of the Phase II randomized French trial PRODIGE 21 comparing sorafenib vs pravastatin vs sorafenib and pravastatin vs best supportive care for the palliative treatment of HCC in CHILD B cirrhotic patients

Authors :: F. Audemar
Jean-Marc Perarnau
Jean-Pierre Bronowicki
F. Khemissa
C. Locher
V. Bourgeois
Charlotte Costentin
Jean-François Seitz
H. Senellart
I. Mabile-Archambeaud
Roger Faroux
S. Obled
Julien Edeline
M.B. Abdelghani
Carole Monterymard
Sylvain Manfredi
G. Delplanque
Anne-Laure Villing
J.-F. Blanc
Source :: Journal of Hepatology. 68:S195
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Oncology
Sorafenib
medicine.medical_specialty
Hepatology
Palliative treatment
business.industry
03 medical and health sciences
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
Medicine
030211 gastroenterology & hepatology
business
Pravastatin
medicine.drug

Full Text Access

Tools